Viracta Therapeutics Stock (NASDAQ:VIRX), Quotes and News Summary

Q: What sector and industry does Viracta Therapeutics (VIRX) operate in?

Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Viracta Therapeutics Stock (NASDAQ: VIRX) stock price, news, charts, stock research, profile.

Open	$0.910
Close	$0.909
Volume / Avg.	79.490K / 115.375K
Day Range	0.851 - 0.990
52 Wk Range	0.430 - 2.380
Market Cap	$33.916M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	2.09%
Days to Cover	8.38

Recent News

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

Avi Kapoor

Why Is Small-Cap Cancer Drug Developer Viracta Therapeutics Stock Trading Lower On Monday?

Nanatinostat combined with valganciclovir shows promising results in treating relapsed or refractory EBV+ peripheral T-cell lymphoma, demonstrating higher efficacy and tolerability than nanatinostat monotherapy.

Vandana Singh

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Viracta Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicine...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Viracta Therapeutics (VIRX) stock?

You can purchase shares of Viracta Therapeutics (NASDAQ: VIRX) through any online brokerage.

View our list of the best stock brokerages.

Who are Viracta Therapeutics's (VIRX) competitors?

Other companies in Viracta Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX) and Bolt Biotherapeutics (NASDAQ:BOLT).

What is the target price for Viracta Therapeutics (VIRX) stock?

The latest price target for Viracta Therapeutics (NASDAQ: VIRX) was reported by Oppenheimer on Wednesday, April 17, 2024. The analyst firm set a price target for 13.00 expecting VIRX to rise to within 12 months (a possible 1405.33% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for Viracta Therapeutics (VIRX)?

The stock price for Viracta Therapeutics (NASDAQ: VIRX) is $0.8636 last updated April 18, 2024 at 6:29 PM EDT.

Does Viracta Therapeutics (VIRX) pay a dividend?

There are no upcoming dividends for Viracta Therapeutics.

When is Viracta Therapeutics (NASDAQ:VIRX) reporting earnings?

Viracta Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.

Is Viracta Therapeutics (VIRX) going to split?

There is no upcoming split for Viracta Therapeutics.

What sector and industry does Viracta Therapeutics (VIRX) operate in?

Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-